targeted protein degradation

WATERTOWN, Mass., April 09, 2026 C4 Therapeutics, Inc. has announced a major expansion of its long-term collaboration with Roche,...

BOSTON and DAEJEON, South Korea, Jan. 4, 2026 — Orum Therapeutics, a biotechnology company pioneering degrader-antibody conjugates (DACs), announced...

BRISBANE, Calif., December 8, 2025 — Nurix Therapeutics has announced compelling new Phase 1 clinical data for its investigational...